PIK3CA and malignant colon neoplasm: Synergistic inhibition of colon cancer cell growth with paclitaxel and the PI3K/mTOR dual inhibitor BEZ235 through apoptosis in HCT116 and HT-29 colon cancer cells has also been reported53.